Effects of 5-bromo-2-deoxyuridine and 2-deoxy-d-glucose on Radiation-induced Micronuclei in Mouse Bone Marrow

References

• Countryman P.I., Heddle J.A. The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutation Research 1976; 41: 321–332
   PubMed Web of Science ®Google Scholar
• Dillehay L.E., Thompson L.H., Carrona A.V. DNA strand breaks associated with halogenated pyrimidines incorporation. Mutation Research 1984; 131: 129–136
   PubMedGoogle Scholar
• Djordjevic B., Szybalski W. Genetics of human cell lines. III. Incorporation of 5-bromo and 5-iodo-2-deoxy-uridine in DNA of human cells and its effect on radiation sensitivity. Journal of Experimental Medicine 1960; 112: 509–531
   PubMed Web of Science ®Google Scholar
• Dwarkanath B.S., Jain V.K. Modification of the radiation induced damage by 2-deoxy-d-glucose in organ cultures of human cerebral gliomas. International Journal of Radiation Oncology, Biology, Physics 1987; 13: 741–746
   PubMed Web of Science ®Google Scholar
• Glastein E. The use of halogenated thymidine analogues as clinical radiosensitizers, rationale current status and future prospects, non hypoxic cell sensitizers. International Journal of Radiation Oncology, Biology, Physics 1984; 10: 1399–1406
   Google Scholar
• Goz B. The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmacological Reviews 1978; 29: 249–272
   Web of Science ®Google Scholar
• Heddle T.J. A rapid in vivo test for chromosomal damage. Mutation Research 1973; 18: 187–190
   PubMed Web of Science ®Google Scholar
• Hoshino T., Sano K. Radiosensitization of malignant brain tumors with bromouridine (thymidine analogue). Acta Radiologica, Therapy, Physics, Biology 1969; 8: 15–26
   PubMed Web of Science ®Google Scholar
• Hsu T.C., Somers C.E. Effects of 5-bromodeoxy-uridine on mammalian chromosomes. Proceedings of the National Academy of Sciences, U.S.A. 1961; 47: 346–403
   Google Scholar
• Iliakis G., Kurtzman S., Pantelias G., Okayasu R. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on radiation induction of DNA and chromosomes damage and its correlation with cell killing. Radiation Research 1989; 119: 304–304
   Google Scholar
• Jain V.K., Pohlit W., Purohit S.C. Influence of energy metabolism on the repair of X-ray damage in living cells. IV. Effects of 2-deoxy-d-glucose on the repair phenomena during fractionated irradiation of yeast. Radiation and Environmental Biophysics 1975; 12: 315–320
   Google Scholar
• Jain V.K., Kalia V.K., Sharma R., Maharajan V., Menon M. Effects of 2-deoxy-d-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells. International Journal of Radiation Oncology, Biology, Physics 1985; 11: 943–950
   PubMed Web of Science ®Google Scholar
• Jain V.K., Purohit S.C., Pohlit U. Optimization of cancer therapy. Part I, Inhibition of repair of X-ray induced potentially lethal damage by 2-deoxy-d-glucose in Ehrlich ascites tumor cells. Indian Journal of Experimental Biology 1977; 15: 711–713
   PubMed Web of Science ®Google Scholar
• Jain V.K., Kalia V.K., Gopinath P.M., Naqvi S., Kucheria K. Optimization of cancer therapy. Part III. Effects of combining 2-deoxy-d-glucose treatment with gamma radiation on normal mice. Indian Journal of Experimental Biology 1979; 17: 1320–1325
   PubMed Web of Science ®Google Scholar
• Kalia V.K., Jain V.K. 2-Deoxy-d-glucose induced enhancement of radiation damage in 5-bromo-2-deoxy-uridine sensitized mammalian cells. Indian Journal of Medical Research 1987; 85: 580–583
   PubMed Web of Science ®Google Scholar
• Kalia V.K., Jain V.K., Otto F.J. Optimization of cancer therapy. Part IV: Effects of 2-deoxy-d-glucose on radiation induced chromosomal damage in PHA stimulated peripheral human leukocytes. Indian Journal of Experimental Biology 1982; 20: 884–888
   PubMed Web of Science ®Google Scholar
• Kinsella T.J., Donson P.O., Mitchell J.B., Fornace A.J. Enhancement of X-ray induced DNA damage by pretreatment with halogenated pyrimidine analogues. International Journal of Radiation Oncology, Biology, Physics 1987; 13: 733–739
   PubMed Web of Science ®Google Scholar
• Kinsella T.J., Russo A., Mitchell J.B., Rowland J., Jenkins J., Schwade J.G., Myres C.E., Collins J.M., Kornblith P., Glastein E. A phase I study of intermittent intravenous bromodeoxy uridine (BrdU) with conventional fractionated irradiation. International Journal of Radiation Oncology, Biology, Physics 1984; 10: 69–76
   PubMed Web of Science ®Google Scholar
• MacGregor J.T., Heddle J.A., Hite M., Margolin B.H., Ramel C., Solamone M.F., Raymond R., Tice W.D. Guidelines for the conduct of micronucleus assay in mammalian bone marrow erythrocytes. Mutation Research 1987; 189: 103–112
   PubMed Web of Science ®Google Scholar
• MacGregor G.W.N., Salamore M.F. The introduction of micronuclei as a measure of genotoxicity. A report of the US Environmental protection agency, Genetox program. Mutation Research 1983; 123: 61–118
   Google Scholar
• Martinez A., Gophinet D.R., Donaldson S.S., Bagshaw M.A., Kaplan H.S. Intra-arterial infusion of radiosensitizer (BrdU) combined with hypofractionated irradiation and chemotherapy for primary treatment of osteogenic sarcoma. International Journal of Radiation Oncology, Biology, Physics 1985; 11: 123–128
   PubMedGoogle Scholar
• Midander J., Revesz L. The frequency of micronuclei as a measure of cell survival in irradiated cell population. International Journal of Radiation Biology 1980; 38: 237–242
   Web of Science ®Google Scholar
• Mohler W.C., Elkind M.M. Radiation response of mammalian cells grown in culture. Modifications of X-ray survival of Chinese hamster cells by 5-bromodeoxyuridine. Experimental Cell Research 1963; 30: 481–491
   Web of Science ®Google Scholar
• Phupanich S., Levin E.M., Levin V.A. Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors. International Journal of Radiation Oncology, Biology, Physics 1984; 10: 1769–1772
   Google Scholar
• Raaphorst G.P., Azzam E.I., Borsa J., Sargent M.D. In vitro transformation by bromodeoxyuridine and X irradiation in C3HIOT½ cells. Radiation Research 1985; 101: 279–291
   Google Scholar
• Sano K., Sato F., Hoshino T., Hagai M. Experimental and clinical studies of radiosensitizers in brain tumors with special reference to BudR-antimetabolites, continuous regional infusion radiotherapy. Neurologia Medico-Chirurgica 1965; 7: 51–62
   Google Scholar
• Schmid W. The micronucleus test. Mutation Research 1975; 31: 9–15
   PubMed Web of Science ®Google Scholar
• Singh S.P., Jain V. Modulation of radiosensitization and radioprotection by 2-deoxy-d-glucose in mouse bone marrow. Indo-German Symposium on Recent Advances in Radiation Oncology. March, 15–19, 1989
   Google Scholar
• Szybalski W. X-ray sensitization by halo-pyrimidines. Cancer Chemotherapy Reports 1974; 58: 539–557
   PubMedGoogle Scholar
• Varahawer N.B., Marshak M.I., Gorbunova L.V., Lukash L.L., Shapiro N.I. The synergistic effects of SV40 and BudR on induction of gene mutations and chromosomal aberrations in Chinese hamster cells. Mutation Research 1980; 70: 351–364
   Google Scholar
• Ward J.F. Molecular mechanism of radiation induced damage to nucleic acids. Advances in Radiation Biology 1975; 5: 18–239
   Google Scholar